Physician profile
Michael Anthony White
NPI 1295955086
$24,548.13
in general payments reported to CMS, 2019-2025
18 companies · $11K in 2025
The $11K reported for 2025 was more than what 94% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $11.08 · 2021: $593 · 2022: $3,421 · 2023: $9,607 · 2024: $38.92 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,350 · Education: $8,000 · Food and Beverage: $2,572 · Travel and Lodging: $733 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,350.02 |
| Education | $8,000.00 |
| Food and Beverage | $2,572.15 |
| Travel and Lodging | $732.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,806.52 | 2019-2023 | Da Vinci Surgical System, Da Vinci Sp |
| Coloplast Corp | $10,272.96 | 2025 | |
| Olympus America INC. | $81.79 | 2025 | Itind System |
| Merck Sharp & Dohme LLC | $72.36 | 2022-2025 | Lynparza, Keytruda Qlex, Keytruda |
| Blue Earth Diagnostics | $45.65 | 2019-2023 | |
| Dendreon Pharmaceuticals LLC | $33.64 | 2025 | Provenge |
| Janssen Biotech, INC. | $33.15 | 2020-2022 | |
| Philips North America LLC | $30.00 | 2025 | Disease Management Solutions Equipment Undivided |
| Avita Medical Americas, LLC | $22.60 | 2023 | Recell |
| Myriad Genetic Laboratories, INC. | $20.16 | 2025 | Prolaris |
| Boston Scientific Corporation | $19.72 | 2024 | |
| Axonics, INC. | $19.20 | 2024 | Axonics |
| Astellas Pharma US INC | $18.39 | 2019 | |
| Amgen INC. | $16.62 | 2019 | |
| Allergan, INC. | $14.88 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.83 | 2025 | |
| Avadel Specialty Pharmaceuticals, LLC | $14.22 | 2019 | |
| Pfizer INC. | $11.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.